Jennifer Dudinak

Jennifer Dudinak is an accomplished regulatory affairs professional with extensive experience in the pharmaceutical industry. Currently serving as Senior Vice President of Global Regulatory Sciences and Global Regulatory Strategy & Policy at Bristol Myers Squibb since October 2019, Jennifer previously held senior leadership positions at Celgene, GSK, Genentech, and Roche, demonstrating a strong focus on oncology and global regulatory affairs. Jennifer's career also includes valuable roles as Program Director at Heart to Hearts, Inc., and Clinical Adjunct Faculty at Rutgers University. Educational qualifications include a Doctor of Pharmacy and registration as a pharmacist from Rutgers University.